Silvio Traversa

Direttore Tecnico/Scientifico/R&S presso SIENNA BIOPHARMACEUTICALS, INC.

54 anni

Health Technology

Consumer Services

Profilo

Silvio Traversa is currently the Chief Scientific Officer at Sienna Biopharmaceuticals, Inc. He was previously the Chief Scientific Officer at Creabilis Therapeutics Srl from 2007 to 2016.
Prior to that, he worked as a Principal at.
Industria Farmaceutica Serono SpA.
Traversa received his undergraduate and doctorate degrees from the University of Turin and his graduate degree from Harvard Business School.

Posizioni attive di Silvio Traversa

Società	Posizione	Inizio
SIENNA BIOPHARMACEUTICALS, INC.	Direttore Tecnico/Scientifico/R&S	01/12/2016

Tutte le posizioni attive di Silvio Traversa

Precedenti posizioni note di Silvio Traversa

Società	Posizione	Fine
Creabilis Therapeutics Srl Creabilis Therapeutics Srl Pharmaceuticals: MajorHealth Technology Creabilis Therapeutics SRL discovers, develops, and markets prescription medicines to treat skin disease. Its products include CT200 and CT335, which is used to treat Behcet's disease; and CT327, which is used for the treatment of psoriasis, atopic dermatitis, and overgrowth of keratinocytes. The company’s products also include CT400, which is used for developing inhibitors of HGMB-1; and CT500 for the treatment of inflammatory disorders. The company was founded by Alfredo Boni in 2003 and is headquartered in Colleretto Giacosa, Italy.	Direttore Tecnico/Scientifico/R&S	01/12/2016
Industria Farmaceutica Serono SpA	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Silvio Traversa

Formazione di Silvio Traversa

University of Turin	Doctorate Degree
Harvard Business School	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Silvio Traversa

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SIENNA BIOPHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Creabilis Therapeutics Srl Creabilis Therapeutics Srl Pharmaceuticals: MajorHealth Technology Creabilis Therapeutics SRL discovers, develops, and markets prescription medicines to treat skin disease. Its products include CT200 and CT335, which is used to treat Behcet's disease; and CT327, which is used for the treatment of psoriasis, atopic dermatitis, and overgrowth of keratinocytes. The company’s products also include CT400, which is used for developing inhibitors of HGMB-1; and CT500 for the treatment of inflammatory disorders. The company was founded by Alfredo Boni in 2003 and is headquartered in Colleretto Giacosa, Italy.	Health Technology
Industria Farmaceutica Serono SpA